体金属有机框架用于基质药物分离
José Navarro-Sánchez1, Ana I Argente-García2, Yolanda Moliner-Martínez2
1Instituto de Ciencia Molecular, Universidad de Valencia , 46980 Paterna, Spain.
Journal of the American Chemical Society
|March 10, 2017
概括
这项研究引入了用于分离药物反体的合金属有机框架 (MOF). 这种新型的Cu (GHG) MOF有效地从血混合物中分离 (+) - 乙,证明了在奇拉性药物分离方面取得了突破.
科学领域:
- 材料科学
- 基质化学
- 分离科学
背景情况:
- 对药物的有效性和安全性至关重要.
- 金属有机框架 (MOF) 为高级分离应用提供可调节的特性.
- 开发有效的分离极性药物的方法仍然是一个挑战.
研究的目的:
- 合成并利用一种合的3D金属有机框架 (MOF) 进行反选择性分离.
- 研究MOF的药物反体的性识别机制.
- 为了证明MOF在分离像甲基胺和乙这样的极性药物的能力.
主要方法:
- 使用Gly-l-His-Gly (GHG) 合成一种奇拉Cu(II) 3D MOF.
- 在固体相提取中使用Cu (GHG) MOF作为提取相.
- 使用蒙特卡洛模拟来阐明性识别机制.
主要成果:
- 这种Cu (GHG) MOF成功地实现了甲基胺和乙胺的分离.
- 蒙特卡洛模拟表明,由于较强或额外的键,一个反体具有优势的结合.
- 使用Cu (GHG) 的固体相提取仅在4分钟内分离出超过50%的 (+) - 乙.
结论:
- 这项工作介绍了第一个能够分离奇拉极性药物的MOF.
- 合Cu (GHG) MOF在选分离中表现出高效率和速度.
- 这些发现为MOF在药物分析和净化中的应用开辟了新的途径.
更多相关视频
10:27Preparation of Highly Porous Coordination Polymer Coatings on Macroporous Polymer Monoliths for Enhanced Enrichment of Phosphopeptides
Published on: July 14, 2015
10.5K
07:45Electrophoretic Crystallization of Ultrathin High-performance Metal-organic Framework Membranes
Published on: August 16, 2018
10.5K
相关概念视频
Extraction: Advanced Methods
1.2K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.2K
Prochirality
5.2K
The concept of prochirality leads to the nomenclature of the individual faces of a molecule and plays a crucial role in the enantioselective reaction. It is a concept where two or more achiral molecules react to produce chiral products. A typical process is the reaction of an achiral ketone to generate a chiral alcohol. Here, the achiral reactant reacts with an achiral reducing agent, sodium borohydride, to generate an equimolar mixture of the chiral enantiomers of the product. For example, an...
5.2K
Affinity Chromatography
3.3K
Affinity chromatography is a powerful technique extensively utilized for separating and purifying specific biomolecules from complex mixtures. It capitalizes on the highly selective binding between an analyte and its counterpart, such as antibody-antigen interactions. The counterpart is immobilized on the stationary phase, forming an affinity column. The stationary phase typically consists of solid support, such as agarose or porous glass beads, immobilizing the affinity ligand. The mobile...
3.3K
Ion-Exchange Chromatography
2.5K
Ion-exchange chromatography, or IEC, is a technique for separating ions based on their affinity for the stationary phase. The stationary phase is a cross-linked polymer resin with covalently attached ionic functional groups. The functional groups can be either positively charged (cation exchangers) or negatively charged (anion exchangers). A cation exchanger consists of a polymeric anion and active cations, while an anion exchanger is a polymeric cation with active anions. The choice of...
2.5K
Chirality in Nature
17.5K
Chirality is the most intriguing yet essential facet of nature, governing life’s biochemical processes and precision. It can be observed from a snail shell pattern in a macroscopic world to an amino acid, the minutest building block of life. Most of the snails around the world have right-coiled shells because of the intrinsic chirality in their genes. All the amino acids present in the human body exist in an enantiomerically pure state, except for glycine - the sole achiral amino acid.
17.5K
